Author Topic: NPF - New Topical for Plaque Psoriasis  (Read 2416 times)

0 Members and 1 Guest are viewing this topic.

Offline CalamityJane

  • SkinCell Grand
  • of Whimsy
  • *****
  • Posts: 3291
  • Gender: Female
  • Dogs speak every language!
NPF - New Topical for Plaque Psoriasis
« on: Saturday October 24, 2015, 03:38:04 AM »
Just received email from National Psoriasis Foundation as follows:

New topical approved for treatment of plaque psoriasis

Earlier this week, the Food and Drug Administration approved Enstilar as a new topical therapy for plaque psoriasis in adults.

Enstilar is a foam thatís a combination of two medications: calcipotriene, a vitamin D-based treatment, and betamethasone dipropionate, a corticosteroid. According to a statement released by LEO Pharma Inc., the makers of Enstilar, it is meant to be used once a day for up to four weeks, and can be applied across large areas of psoriasis on the body. It is expected to be available in pharmacies in January 2016.

A Phase III clinical trial found that more than half of the patients using the foam had clear or almost clear skin after one month of use and achieved at least 75 percent improvement in their psoriasis severity, according to LEO.

For more information, visit

I hope this will help!

It's a good day when you laugh!